Discover 1,294 paid clinical trials in Chandler, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,294
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
for
Narcolepsy Type 2
Location: Phoenix AZ, Los Angeles CA, Boulder CO, San Antonio TX,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT07502443
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
for
Narcolepsy Type 1
Location: Phoenix AZ, Los Angeles CA, Boulder CO, San Antonio TX,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT07455383
Phase 3, Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Location: Scottsdale AZ, San Diego CA, Santa Ana CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 6 - 17
Code: NCT05723198
Phase 3, Recruiting
Operative vs Non-Operative Treatment of Sacral Fractures
for
Sacral Fracture
Location: Phoenix AZ
Sponsor: More Foundation
Sex: All
Age: 60+
Code: NCT04044300
Recruiting
Pompe Disease Registry Protocol
for
Glycogen Storage Disease Type II, Pompe Disease
Location: Phoenix AZ, Tucson AZ, Las Vegas NV, Irvine CA,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00231400
Recruiting
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
for
Amblyopia
Location: Scottsdale AZ, Glendale AZ, Tucson AZ, Pomona CA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 8 - 12
Code: NCT06524882
Phase 3, Recruiting
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
for
Amblyopia
Location: Scottsdale AZ, Glendale AZ, Tucson AZ, San Diego CA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 4 - 7
Code: NCT06380517
Phase 3, Recruiting
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors
for
Solid Tumor
Location: Phoenix AZ, Iowa City IA, Edgewood KY, Pittsburgh PA
Sponsor: Oxford BioTherapeutics Ltd
Sex: All
Age: 18+
Code: NCT04064359
Phase 1, Recruiting
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
for
KRAS G12C Mutation, KRAS G12S Mutation,
Location: Phoenix AZ, Denver CO, San Antonio TX, Oklahoma City OK,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT06720987
Phase 1, Recruiting
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Phoenix AZ, Burbank CA, Grand Junction CO, Reno NV,